ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

GAO Backs DeVita On Why advances Aren’t Producing Mortality Reduction

February 5, 1988

Obituary: Edwin Fisher, NSABP Pathologist.

April 4, 2008

Move to Boycott Cancer Congress Gains Some Support

January 20, 1978

Racial Disparities Persist In Diagnosis Of Advanced Breast Cancer, Colon Cancer

February 26, 2010

Coalitions Urges Members To Call, Write, Congress

May 3, 1991

NCI To Fund 840 Competing Grants In FY 1991; No Downward Negotiations, But Careful Review

December 7, 1990